Social Capital Hedosophia Re-Files with a 1/3 Warrant
by Kristi Marvin on 2020-03-18 at 8:00am

Social Capital Hedosophia, which was anticipated to price SPACs II & III on Monday night, but delayed due to market conditions, re-filed new prospectuses this morning with a notable change to both – their warrants included in their units, which were originally 1/4 warrants, are now 1/3 warrants.

Both Social Capital Hedosophia II (IPOB.U) and Social Capital Hedosophia III (IPOC.U), are big, brand-name SPACs, being led by Chamath Palihapitiya.  So going from a 1/4 warrant to a 1/3 warrant is indicative of the larger, current market environment.  If any of the current deals getting ready to IPO should be able to command a 1/4 warrant, it should be the Social Capital teams. But these are not normal times and the Coronavirus has had such a profound impact on the capital markets that changes were inevitable.

It’s been a real race to get the current crop of IPOs out the door before deal terms needed to be adjusted.  However, it looks like the larger market environment has finally caught up to SPACs.  Whether Social Capital’s warrant changes are meaningful enough to sell $900 million worth of SPACs remains to be seen, but terms will continue to tighten across the entire spectrum of SPAC sizes and levels.

No other significant changes were found in the prospectus of either IPOB.U and IPOC.U, and you can find the S-1 filings for SCH2 HERE and SCH3 HERE.

 

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-03-26 at 1:52pm

News and Rumors SpaceNews: Boeing (NYSE:BA) has sued Virgin Galactic (NASDAQ:SPCE) alleging the space tourism venture refused to pay $25 million it owed for design work and violated Boeing’s intellectual property rights. Virgin Galactic combined with Social Capital Hedosophia in 2019. Bloomberg: The most popular options contract for Trump Media (NASDAQ:DJT) predicts it to plunge...

by Nicholas Alan Clayton on 2024-03-26 at 11:51am

APx (NASDAQ:APXI) has entered into a definitive agreement to combine with precision medicine firms OmnigenicsAI and MultiplAI at an enterprise value $340 million. Once combined, these companies will offer DNA tests to consumers linked to predictive insights on their nutritional and genomic health. The combined company is expected to trade on the Nasdaq under the...

by Nicholas Alan Clayton on 2024-03-26 at 7:45am

At the SPAC of Dawn With the pricing of IB Acquisition Corp. (NASDAQ:IBACU), March now officially has two SPAC IPOs in the books but we”ll have to see if three price to match February’s numbers. The move brings 2024’s total count to six SPAC IPOs, which continues to be a slower pace than 2023, which turned...

by Kristi Marvin on 2024-03-25 at 6:37pm

IB Acquisition Corp. (NASDAQ:IBACU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “IBACU”, Tuesday, March 26, 2024. The new SPAC will have a broad search focus and will not be limited to a particular geographic region or industry, but believe there...

by Kristi Marvin on 2024-03-25 at 3:24pm

They say timing is everything and at the end of a week punctuated by two successful traditional IPOs from Astera and Reddit, the sponsor team that announced the CCIV/Lucid deal at the absolute peak of the capital markets insanity that was Q1-2021 dropped their latest new SPAC – Churchill Capital Corp. IX. Is this a...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved